Literature DB >> 32127229

Hospital-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2019 Update.

Antoni Torres1, José Barberán2, Adrian Ceccato3, Ignacio Martin-Loeches4, Miguel Ferrer5, Rosario Menéndez6, David Rigau7.   

Abstract

Hospital-acquired pneumonia (HAP) is the second leading cause of nosocomial infection, and increases morbidity and mortality. It is currently classified into three groups: HAP not requiring artificial ventilation, HAP requiring artificial ventilation, and HAP acquired during artificial ventilation, also known as ventilator-acquired pneumonia (VAP). The latest guidelines for the management of HAP were published in 2016 (IDSA/ATS) and 2017 (ERS/ESCMID/ESICM and ALAT). The latest Spanish guidelines were published in Archivos de Bronconeumologia in 2011. American guidelines from 2016 and international guidelines from 2017 present their recommendations in a context of significantly increased resistance of both Gram-positive and, in particular, Gram-negative microorganisms to antibacterial agents. In 2019, SEPAR celebrated Pneumonia Year, and we felt that this was an appropriate time to update the guidelines published in 2011. Pulmonologists, intensive care specialists, infectious disease specialists, and methodology experts participated in drawing up this document, and agreed to use the following scheme.
Copyright © 2020 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Keywords:  Extensively drug-resistant (XDR) microorganisms; Hospital-acquired pneumonia; Microorganismos extremadamente resistentes (XDR); Microorganismos multirresistentes (MDR); Multidrug-resistant (MDR) microorganisms; Neumonia asociada a la ventilación mecánica; Neumonia intrahospitalaria; Neumonia nosocomial; Nosocomial pneumonia; Ventilator-associated pneumonia

Mesh:

Substances:

Year:  2020        PMID: 32127229     DOI: 10.1016/j.arbres.2020.01.015

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  40 in total

1.  An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy.

Authors:  Oriol Roca; Berta Caralt; Jonathan Messika; Manuel Samper; Benjamin Sztrymf; Gonzalo Hernández; Marina García-de-Acilu; Jean-Pierre Frat; Joan R Masclans; Jean-Damien Ricard
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

2.  Risk Factors for Noninvasive Ventilation Failure in Critically Ill Subjects With Confirmed Influenza Infection.

Authors:  Alejandro Rodríguez; Cristina Ferri; Ignacio Martin-Loeches; Emili Díaz; Joan R Masclans; Federico Gordo; Jordi Sole-Violán; María Bodí; Francesc X Avilés-Jurado; Sandra Trefler; Monica Magret; Gerard Moreno; Luis F Reyes; Judith Marin-Corral; Juan C Yebenes; Andres Esteban; Antonio Anzueto; Stefano Aliberti; Marcos I Restrepo
Journal:  Respir Care       Date:  2017-07-11       Impact factor: 2.258

3.  Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation.

Authors:  Elisa Estenssoro; Fernando G Ríos; Carlos Apezteguía; Rosa Reina; Jorge Neira; Daniel H Ceraso; Cristina Orlandi; Ricardo Valentini; Norberto Tiribelli; Matías Brizuela; Carina Balasini; Sebastián Mare; Gustavo Domeniconi; Santiago Ilutovich; Alejandro Gómez; Javiera Giuliani; Cecilia Barrios; Pascual Valdez
Journal:  Am J Respir Crit Care Med       Date:  2010-03-04       Impact factor: 21.405

Review 4.  Lung-protective ventilation strategies and adjunctive treatments for the emergency medicine patient with acute respiratory failure.

Authors:  Brian J Wright
Journal:  Emerg Med Clin North Am       Date:  2014-09-18       Impact factor: 2.264

5.  High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.

Authors:  Jean-Pierre Frat; Arnaud W Thille; Alain Mercat; Christophe Girault; Stéphanie Ragot; Sébastien Perbet; Gwénael Prat; Thierry Boulain; Elise Morawiec; Alice Cottereau; Jérôme Devaquet; Saad Nseir; Keyvan Razazi; Jean-Paul Mira; Laurent Argaud; Jean-Charles Chakarian; Jean-Damien Ricard; Xavier Wittebole; Stéphanie Chevalier; Alexandre Herbland; Muriel Fartoukh; Jean-Michel Constantin; Jean-Marie Tonnelier; Marc Pierrot; Armelle Mathonnet; Gaëtan Béduneau; Céline Delétage-Métreau; Jean-Christophe M Richard; Laurent Brochard; René Robert
Journal:  N Engl J Med       Date:  2015-05-17       Impact factor: 91.245

6.  Comparison of high-flow nasal cannula versus oxygen face mask for environmental bacterial contamination in critically ill pneumonia patients: a randomized controlled crossover trial.

Authors:  C C H Leung; G M Joynt; C D Gomersall; W T Wong; A Lee; L Ling; P K S Chan; P C W Lui; P C Y Tsoi; C M Ling; M Hui
Journal:  J Hosp Infect       Date:  2018-10-15       Impact factor: 3.926

7.  Early non-invasive ventilation treatment for severe influenza pneumonia.

Authors:  J R Masclans; M Pérez; J Almirall; L Lorente; A Marqués; L Socias; L Vidaur; J Rello
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

8.  Noninvasive positive-pressure ventilation: An experimental model to assess air and particle dispersion.

Authors:  David S Hui; Stephen D Hall; Matthew T V Chan; Benny K Chow; Jin Y Tsou; Gavin M Joynt; Colin E Sullivan; Joseph J Y Sung
Journal:  Chest       Date:  2006-09       Impact factor: 9.410

9.  MERS transmission and risk factors: a systematic review.

Authors:  Ji-Eun Park; Soyoung Jung; Aeran Kim; Ji-Eun Park
Journal:  BMC Public Health       Date:  2018-05-02       Impact factor: 3.295

10.  The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Authors:  Noah C Peeri; Nistha Shrestha; Md Siddikur Rahman; Rafdzah Zaki; Zhengqi Tan; Saana Bibi; Mahdi Baghbanzadeh; Nasrin Aghamohammadi; Wenyi Zhang; Ubydul Haque
Journal:  Int J Epidemiol       Date:  2020-06-01       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.